SynopsisMagnetic resonance imaging (MRI) has rapidly become a leading research tool in the study of multiple sclerosis (MS). Conventional imaging is useful in diagnosis and management of the inflammatory stages of MS, but has limitations in describing the degree of tissue injury as well as the cause of progressive disability seen in the later stages of disease. Advanced MRI techniques hold promise to fill this void. Magnetization transfer imaging is a widely available technique that can characterize demyelination and may be useful in measuring putative remyelinating therapies. Diffusion tensor imaging describes the three-dimensional diffusion of water and holds promise in characterizing neurodegeneration and putative neuroprotective therapies. Spectroscopy measures the imbalance of cellular metabolites and could help unravel the pathogenesis of neurodegeneration in MS. Functional (f) MRI can be used to understand the functional consequences of MS injury, including the impact on cortical function and compensatory mechanisms. These imaging tools hold great promise to increase our understanding of MS pathogenesis and provide greater insight into the efficacy of new MS therapies.
Keywords
MRI; imaging; magnetization transfer imaging; spectroscopy; functional MRI; diffusion tensor imaging
IntroductionMagnetic resonance imaging (MRI) is a non-invasive imaging technique, providing excellent contrast between intact and demyelinated white matter. MRI lesions typically persist for decades, providing a long term record of MS injury within the brain and spinal cord. MRI was formally integrated into the MS diagnostic criteria in 2000 and can be used © 2010 Elsevier Inc. All rights reserved.Corresponding Author: Robert J. Fox, MD, Mellen Center for Multiple Sclerosis, 9500 Euclid Ave, U-10, Cleveland, OH 44122, FOXR@ccf.org. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 105 MRI also has been an important tool in the study of new MS agents, where reduction in new lesions is usually the primary outcome of phase II trials of anti-inflammatory therapies.
NIH Public AccessConventional MRI modalities include T2-weighted, T1-weighted, and post-gadolinium T1-weighted images. Although useful in the diagnosis and management of MS, conventional imaging has several limitations. Lesions are non-specific, indicating areas of inflammation, demyelination, ischemia, edema, cell loss, gliosis. Conventional imaging is unable to differentiate between these different pathologies. Conventional imaging also poorly characterizes the degree of injury in demyelinated lesions. In addition, conventional imagin...